Google’s Alphabet Incorporation to sell robot-manufacturing firms Schaft and Boston Dynamics to Japan’ Softbank Group
Date: 2017-06-22   Author: Dhananjay Punekar  Category: #news

Softbank Group, a multinational telecommunications & internet firm based in Japan, has decided to purchase robot maker Boston Dynamics from Alphabet Incorporation, a U.S. based multinational firm and a parent company of Google, to be a forerunner in the smart robotics business. The transaction is also expected to support the growth of Japan robotics industry and offer bright future prospects for the overall robotics industry. As per the deal, SoftBank will also purchase Schaft, a reputed Japanese robotics company, from Alphabet Inc. The former had already developed Pepper, the world’s first robot that is reputed to have the ability to understand human emotions.

Boston Dynamics, a spin off from the Massachusetts Institute of Technology & the first developer of robots that were designed to exhibit animal-like traits, has always remained at the forefront of the news columns, having had the reputation of being mentioned in myriad news snippets on a daily basis. It had already created the robots that can jump, climb staircase, and run. The firm had constantly displayed its ability to manufacture new robots resembling animal prototypes which could trek across all kinds of landscape. It had also posted online videos more often on the web and social networking sites. The robot maker claims that it has already developed two robots, one of which runs as fast as 20 miles/hour, and the other that is designed to accompany marines on job and help them by carrying 500 kilos of load.

Analysts have predicted that the robotics industry has tremendous growth potential. Consequently, firms such as Softbank are expected to make notable contributions towards the expansion of this industry. Last year, Softbank had set a vision to enter artificial intelligence, smart robotics, and IoT (Internet of Things) business. The firm is the key merger & acquisition participant in the tech fraternity and had already acquired ARM, a UK based chip designer. A few days back, Saudi Arabia and Softbank also launched a wealth fund worth USD 100 billion, termed as a vision fund which will make investments in artificial intelligence and robotics.

Experts state the world has been facing critical issues since the last few years that human beings, in all probability, may be unable to resolve. These issues are likely to be solved to an extent only with the help of advanced technologies such as smart robotics. Softbank’s mission borders on producing technologically dynamic robots that will form a vital component of the new technological revolution with their ability to benefit mankind through their extensive utilization across the globe.

About Author

Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay

Post Recommendents

Alibaba prioritizes SEA expansion, pours in USD 2bn more in Lazada
Author: Dhananjay Punekar

Alibaba Group Holding Limited, a Chinese eCommerce & retail firm, is expected to provide an additional investment worth USD 2 billion to Lazada Group SA, an eCommerce firm headquartered in Singapore.  Incident...

Grofers secures USD 61.6 million in funding round led by SoftBank
Author: Dhananjay Punekar

Grofers, an India-based online grocery delivery service, has received funds worth USD 61.6 million from SoftBank Group via its initial fund-raising round. Incidentally, the round also witnessed the participation of Apo...

Mayne Pharma Group launches a generic alternative to Monodox in U.S.
Author: Sunil Hebbalkar

Mayne Pharma Group, the Australia-headquartered drug delivery conglomerate, has recently announced the launch of doxycycline monohydrate IR capsules in the United States. Reportedly, the scarcely launched drug is a gen...